For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

IGF-1 DES (1-3) Dosage Chart & Schedule

IGF-1 DES(1-3) is a truncated form of insulin-like growth factor 1 missing its first three N-terminal amino acids, a change that sharply lowers binding to IGF-binding proteins and increases potency. It is a laboratory research reagent with no approved human use and essentially no controlled human data.

Route
Subcutaneous
Frequency
Post-workout (research)
Half-life
Short
Storage
Lyophilized: cool or frozen. Reconstituted: refrigerate 2-8 C.
The short answer

IGF-1 DES(1-3) is a truncated, more potent IGF-1 analog used only as a laboratory and animal research reagent, with no approved human use and essentially no controlled human data. Non-clinical sources reference small localized amounts (roughly 20-50 mcg), but no validated human dosing exists.

Figures describe how IGF-1 DES (1-3) is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Starter
20 mcg
About 4 units at 500 mcg/mL (1 mg + 2 mL)
Frequency
Post-workout on training days (non-clinical reference)
Weekly total
About 60-80 mcg/week (training days)
Cycle
No established cycle; short non-clinical references only

Low end of the range cited on non-clinical forums.

Most commonStandard
40 mcg
About 8 units at 500 mcg/mL (1 mg + 2 mL)
Frequency
Post-workout on training days (non-clinical reference)
Weekly total
About 120-160 mcg/week (training days)
Cycle
No established cycle; short non-clinical references only

Mid-range of forum figures (about 20-50 mcg); not a validated dose.

No human dosing exists

  • IGF-1 DES(1-3) has no approved human use and essentially no controlled human data.
  • Dose figures around 20-50 mcg come from non-clinical forums, not validated protocols.
  • Removing the first three N-terminal residues lowers IGF-binding-protein capture, making it more potent than native IGF-1.

Ready to run this protocol?

Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

IGF-1 DES (1-3) reconstitution

Research lyophilate. A 1 mg vial reconstituted with 2 mL bacteriostatic water yields 500 mcg/mL; on a U-100 syringe 1 unit (0.01 mL) is about 5 mcg. Research use only.

Concentration
500 mcg/mL
Per syringe unit
5 mcg
Draw for 40 mcg
8 units
Doses per vial
~25
Open this mix in the calculator →

From vial to injection in 6 steps

1

Wipe both vial tops

Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.

2

Draw the water

Pull the planned amount of bacteriostatic water (2 mL) into the syringe.

3

Add it slowly

Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.

4

Let it dissolve

Wait until the solution is fully clear, then refrigerate the vial.

5

Draw your dose

Pull the calculated units on a U-100 insulin syringe (~8 units for 40 mcg).

6

Store between uses

Keep the reconstituted vial refrigerated and use within its stable window.

Handling & storage

  • A 1 mg vial with 2 mL bacteriostatic water gives 500 mcg/mL; one U-100 unit is about 5 mcg.
  • Reconstitute gently and refrigerate; IGF peptides are fragile in solution.
  • Because free IGF-1 clears within minutes, non-clinical use references timing around training.
  • Research use only; high potency means small volume changes shift the amount substantially.

IGF-1 DES (1-3) dosing FAQ

Is there an established human dose for IGF-1 DES?

No. It is a laboratory and animal research reagent with no approved human use; figures around 20-50 mcg come from non-clinical forums, not validated protocols.

How much is in one syringe unit?

At the common 1 mg + 2 mL mix (500 mcg/mL), one U-100 unit (0.01 mL) is about 5 mcg, so a 40 mcg reference amount is roughly 8 units.

How does it differ from IGF-1 LR3 on dosing?

Both evade IGF-binding proteins, but DES(1-3) is very short-acting while LR3 is long-acting; non-clinical references dose DES around training rather than once daily.

Why is timing described as post-workout?

Because free IGF-1 clears within minutes, non-clinical sources reference administration close to training near the worked area. This is reported context, not a recommendation.

Sources

Categories: Healing & Recovery · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.